T5O — bioXXmed AG Balance Sheet
0.000.00%
Last trade - 00:00
- €2.85m
- €1.77m
- €0.01m
- 27
- 30
- 16
- 13
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | — | — | — | GAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.69 | 2.01 | 1.57 | 0.001 | 1.84 |
Net Total Receivables | 0.062 | 0.032 | 0.108 | 0.102 | 0.099 |
Prepaid Expenses | |||||
Total Current Assets | 2.99 | 2.07 | 1.72 | 0.11 | 1.95 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.015 | 0.021 | 0.015 | 0.002 | 0.001 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 16.4 | 17.9 | 22.3 | 18.3 | 21.6 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.82 | 0.059 | 0.111 | 0.233 | 0.044 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.87 | 0.111 | 0.37 | 0.4 | 0.189 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 13.5 | 17.7 | 21.9 | 17.9 | 21.4 |
Total Liabilities & Shareholders' Equity | 16.4 | 17.9 | 22.3 | 18.3 | 21.6 |
Total Common Shares Outstanding |